latoconazole (lanoconazole)

01/01/2001 - "Usefulness of lanoconazole (Astat) cream in the treatment of hyperkeratotic type tinea pedis. "
08/01/1991 - "Both the recently developed tinea pedis model and the conventional tinea model in guinea pigs were employed for evaluation of topical usefulness of latoconazole. "
09/01/1994 - "These studies, therefore, suggested that ointment and cream preparations of lanoconazole on topical application in the tinea pedis model would show basically equivalent therapeutic efficacy."
09/01/1994 - "The therapeutic efficacy of ointment and cream preparations of lanoconazole in a guinea pig model of tinea pedis was compared. "
09/01/1994 - "[Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea pedis, in comparison with that of cream preparations]."

03/01/1992 - "Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs."
08/01/1991 - "Antifungal activity of the new agent latoconazole in two tinea models."
08/01/1991 - "Both the recently developed tinea pedis model and the conventional tinea model in guinea pigs were employed for evaluation of topical usefulness of latoconazole. "
08/01/1991 - "The 1% solution or cream preparation of latoconazole was highly effective in both of the two tinea models and its 5 or more doses achieved almost complete mycological cure. "
01/01/1995 - "These studies, therefore, suggested that ointment and cream preparations of lanoconazole on topical application would show basically equivalent therapeutic efficacy in the tinea corporis model."

09/01/1997 - "To answer the question why topically applied lanoconazole (CAS 101530-10-3, NND-318) is so highly effective in the treatment of dermatomycoses in both animal models and human patients, the antifungal activity of lanoconazole in infected sites was investigated. "
01/01/2006 - "Meanwhile, the MIC90 values of lanoconazole and luliconazole, known to be antifungal drugs potent against dermatomycosis, were 0.00078 and 0.00039 microg/ ml, respectively. "
08/01/1991 - "These results suggest that latoconazole is a promising topical antifungal agent, probably applicable to the treatment of tinea pedis as well as other types of dermatomycoses."
10/01/1999 - "To investigate the mode of action of the newly synthesized optically active imidazole compound, NND-502, (-)-(E)-[4-(2, 4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolylacetonit rile, its effect on ergosterol biosynthesis in cell-free extracts of Candida albicans was examined and compared with that of the (S)-enantiomer of NND-502 in addition to lanoconazole and bifonazole, both of which are clinically used for the treatment of dermatomycoses. "

09/01/1994 - "Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs."
01/01/2002 - "Lanoconazole, an imidazole, is a topical agent with potential application in tinea infections and cutaneous candidiasis. "
09/01/1994 - "The therapeutic efficacy of 1% cream and 1% solution of lanoconazole, a new imidazole antimycotic agent, in the model of cutaneous candidiasis in prednisolone-treated guinea pigs was evaluated in comparison with that of comparable formulations of bifonazole. "
08/01/2004 - "The minimum inhibitory concentration (MIC) values for luliconazole were compared with those of three reference drugs, lanoconazole (LCZ), bifonazole (BFZ), and terbinafine (TBF), all of which have been popular for the topical treatment of dermatophytosis, cutaneous candidiasis, and other superficial fungal infections in Japan. "

07/01/1996 - "Allergic contact dermatitis from lanoconazole."
10/01/2020 - "Allergic contact dermatitis due to clobetasol propionate and lanoconazole."
10/01/2000 - "Allergic contact dermatitis from diethyl sebacate in lanoconazole cream."
01/01/1998 - "Allergic contact dermatitis due to lanoconazole with no cross-reactivity to other imidazoles."
01/01/2001 - "Allergic contact dermatitis due to both lanoconazole and neticonazole ointments."